BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32007924)

  • 1. Tumor-stroma interaction increases CD147 expression in neoplastic B lymphocytes in chronic lymphocytic leukemia.
    Rodriguez CM; Gilardoni MB; Remedi MM; Sastre D; Heller V; Pellizas CG; Donadio AC
    Blood Cells Mol Dis; 2020 May; 82():102405. PubMed ID: 32007924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid tumor cells-fibroblasts crosstalk: role of extracellular vesicles.
    Bravo-Miana RDC; Della Vedova AB; De Paul AL; Remedi MM; Guantay ML; Gilardoni MB; Pellizas CG; Donadio AC
    Endocr Connect; 2020 Jun; 9(6):506-518. PubMed ID: 32485677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications.
    Crompot E; Van Damme M; Pieters K; Vermeersch M; Perez-Morga D; Mineur P; Maerevoet M; Meuleman N; Bron D; Lagneaux L; Stamatopoulos B
    Haematologica; 2017 Sep; 102(9):1594-1604. PubMed ID: 28596280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells.
    Lagneaux L; Delforge A; De Bruyn C; Bernier M; Bron D
    Leuk Lymphoma; 1999 Nov; 35(5-6):445-53. PubMed ID: 10609782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells.
    Lagneaux L; Delforge A; Bron D; De Bruyn C; Stryckmans P
    Blood; 1998 Apr; 91(7):2387-96. PubMed ID: 9516138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival.
    Trimarco V; Ave E; Facco M; Chiodin G; Frezzato F; Martini V; Gattazzo C; Lessi F; Giorgi CA; Visentin A; Castelli M; Severin F; Zambello R; Piazza F; Semenzato G; Trentin L
    Oncotarget; 2015 Dec; 6(39):42130-49. PubMed ID: 26517523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.
    Maffei R; Fiorcari S; Bulgarelli J; Martinelli S; Castelli I; Deaglio S; Debbia G; Fontana M; Coluccio V; Bonacorsi G; Zucchini P; Narni F; Torelli G; Luppi M; Marasca R
    Haematologica; 2012 Jun; 97(6):952-60. PubMed ID: 22207686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance.
    Van Damme M; Crompot E; Meuleman N; Maerevoet M; Mineur P; Bron D; Lagneaux L; Stamatopoulos B
    Clin Epigenetics; 2016; 8():132. PubMed ID: 27980696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target.
    Hegde GV; Peterson KJ; Emanuel K; Mittal AK; Joshi AD; Dickinson JD; Kollessery GJ; Bociek RG; Bierman P; Vose JM; Weisenburger DD; Joshi SS
    Mol Cancer Res; 2008 Dec; 6(12):1928-36. PubMed ID: 19074837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation in Chronic Lymphocytic Leukemia Cells.
    Vangapandu HV; Ayres ML; Bristow CA; Wierda WG; Keating MJ; Balakrishnan K; Stellrecht CM; Gandhi V
    Neoplasia; 2017 Oct; 19(10):762-771. PubMed ID: 28863345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment.
    Valsecchi R; Coltella N; Belloni D; Ponente M; Ten Hacken E; Scielzo C; Scarfò L; Bertilaccio MT; Brambilla P; Lenti E; Martinelli Boneschi F; Brendolan A; Ferrero E; Ferrarini M; Ghia P; Tonon G; Ponzoni M; Caligaris-Cappio F; Bernardi R
    Blood; 2016 Apr; 127(16):1987-97. PubMed ID: 26825709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis.
    Vosoughi T; Bagheri M; Hosseinzadeh M; Ehsanpour A; Davari N; Saki N
    J Cell Physiol; 2019 Nov; 234(11):19420-19439. PubMed ID: 31049958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironment.
    Kriston C; Plander M; Márk Á; Sebestyén A; Bugyik E; Matolcsy A; Barna G
    Ann Hematol; 2018 Nov; 97(11):2145-2152. PubMed ID: 29955944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
    Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
    Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Mcl-1 expression in context to bone marrow stromal microenvironment in chronic lymphocytic leukemia.
    Balakrishnan K; Burger JA; Fu M; Doifode T; Wierda WG; Gandhi V
    Neoplasia; 2014 Dec; 16(12):1036-46. PubMed ID: 25499217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia.
    Giannoni P; Cutrona G; Totero D
    Curr Mol Med; 2017; 17(1):24-33. PubMed ID: 28231754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
    Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
    Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant CD8 expression in B-chronic lymphocytic leukemia: report of five cases.
    Parisi-Duchêne E; Mazurier I; Moskovtchenko P
    Acta Haematol; 2006; 115(1-2):74-7. PubMed ID: 16424654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant morphology, proliferation, and apoptosis of B-cell chronic lymphocytic leukemia cells.
    Bueso-Ramos CE; Ferrajoli A; Medeiros LJ; Keating MJ; Estrov Z
    Hematology; 2004 Aug; 9(4):279-86. PubMed ID: 15621735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.